Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Autoimmune Disorders

  Free Subscription


23.10.2017

6 Brain
1 Curr Opin Immunol
4 Intern Med
1 J Autoimmun
1 J Immunol
1 J Neuroimmunol
1 Lancet
5 Mult Scler
1 N Engl J Med
1 Neurology
18 PLoS One
1 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Brain

  1. ROCCA MA, Sormani MP, Rovaris M, Caputo D, et al
    Long-term disability progression in primary progressive multiple sclerosis: a 15-year study.
    Brain. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available

  2. GRANBERG T, Fan Q, Treaba CA, Ouellette R, et al
    In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Brain. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. SCOLDING NJ, Pasquini M, Reingold SC, Cohen JA, et al
    Cell-based therapeutic strategies for multiple sclerosis.
    Brain. 2017 Jul 21. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. DATTA G, Colasanti A, Rabiner EA, Gunn RN, et al
    Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Brain. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. KALINCIK T, Manouchehrinia A, Sobisek L, Jokubaitis V, et al
    Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.
    Brain. 2017;140:2426-2443.
    PubMed     Text format     Abstract available

  6. HACOHEN Y, Ciccarelli O, Hemingway C
    Abnormal white matter development in children with multiple sclerosis and monophasic acquired demyelination.
    Brain. 2017;140:1172-1174.
    PubMed     Text format    


    Curr Opin Immunol

  7. IVISON S, des Rosiers C, Lesage S, Rioux JD, et al
    Biomarker-guided stratification of autoimmune patients for biologic therapy.
    Curr Opin Immunol. 2017;49:56-63.
    PubMed     Text format     Abstract available


    Intern Med

  8. TAKAHASHI Y, Yamashita T, Morihara R, Nakano Y, et al
    Emergency Caesarean Section Saved Both an Anti-MuSK Antibody-positive Myasthenia Gravis Mother with Pregnancy-induced Hypertension and Her Premature Baby.
    Intern Med. 2017 Oct 16. doi: 10.2169/internalmedicine.8636.
    PubMed     Text format     Abstract available

  9. NAGASHIMA K, Sano I, Kobayashi T, Eto K, et al
    A Case of IgG4-related Lung Pseudotumor and Pleural Inflammation with Autoimmune Hepatitis.
    Intern Med. 2017 Oct 16. doi: 10.2169/internalmedicine.9026.
    PubMed     Text format     Abstract available

  10. OKA S, Ono K, Nohgawa M
    Successful Treatment of Catastrophic Antiphospholipid Antibody Syndrome Associated with MALT Lymphoma by Autologous Hematopoietic Stem Cell Transplantation.
    Intern Med. 2017;56:1207-1212.
    PubMed     Text format     Abstract available

  11. ITO M, Hinata T, Tamura K, Koga A, et al
    Disseminated Cryptococcosis with Adrenal Insufficiency and Meningitis in an Immunocompetent Individual.
    Intern Med. 2017;56:1259-1264.
    PubMed     Text format     Abstract available


    J Autoimmun

  12. VARADE J, Wang N, Lim CK, Zhang T, et al
    Novel genetic loci associated HLA-B*08:01 positive myasthenia gravis.
    J Autoimmun. 2017 Oct 13. pii: S0896-8411(17)30565.
    PubMed     Text format     Abstract available


    J Immunol

  13. HAN S, Zhuang H, Shumyak S, Wu J, et al
    A Novel Subset of Anti-Inflammatory CD138+ Macrophages Is Deficient in Mice with Experimental Lupus.
    J Immunol. 2017;199:1261-1274.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  14. BADIHIAN S, Manouchehri N, Badihian N
    More evidence is needed to show any role of cytomegalovisrus and varicella zoster virus in pathogenesis of multiple sclerosis.
    J Neuroimmunol. 2017 Sep 18. pii: S0165-5728(17)30401.
    PubMed     Text format    


    Lancet

  15. GREEN AJ, Gelfand JM, Cree BA, Bevan C, et al
    Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.
    Lancet. 2017 Oct 10. pii: S0140-6736(17)32346.
    PubMed     Text format     Abstract available


    Mult Scler

  16. FOX RJ, Chataway J
    Advancing trial design in progressive multiple sclerosis.
    Mult Scler. 2017;23:1573-1578.
    PubMed     Text format     Abstract available

  17. MILLER DH, Thompson AJ
    Advancing trial design in progressive multiple sclerosis.
    Mult Scler. 2017;23:1571-1572.
    PubMed     Text format    

  18. MOCCIA M, de Stefano N, Barkhof F
    Imaging outcome measures for progressive multiple sclerosis trials.
    Mult Scler. 2017;23:1614-1626.
    PubMed     Text format     Abstract available

  19. PICHLER A, Khalil M, Langkammer C, Pinter D, et al
    The impact of vascular risk factors on brain volume and lesion load in patients with early multiple sclerosis.
    Mult Scler. 2017 Oct 1:1352458517736149. doi: 10.1177/1352458517736149.
    PubMed     Text format     Abstract available

  20. GLAZER CH, Tottenborg SS, Giwercman A, Brauner EV, et al
    Male factor infertility and risk of multiple sclerosis: A register-based cohort study.
    Mult Scler. 2017 Oct 1:1352458517734069. doi: 10.1177/1352458517734069.
    PubMed     Text format     Abstract available


    N Engl J Med

  21. BHATTACHARYYA RP, Flores EJ, Azar MM
    Case 30-2017. A 65-Year-Old Woman with Altered Mental Status, Bacteremia, and Acute Liver Failure.
    N Engl J Med. 2017;377:1274-1282.
    PubMed     Text format    


    Neurology

  22. MUNGER KL, Hongell K, Aivo J, Soilu-Hanninen M, et al
    25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort.
    Neurology. 2017;89:1578-1583.
    PubMed     Text format     Abstract available


    PLoS One

  23. PUTHENPARAMPIL M, Federle L, Poggiali D, Miante S, et al
    Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis.
    PLoS One. 2017;12:e0183957.
    PubMed     Text format     Abstract available

  24. BLAZER A, Wang B, Simpson D, Kirchhoff T, et al
    Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients.
    PLoS One. 2017;12:e0182483.
    PubMed     Text format     Abstract available

  25. CEUNINCK VAN CAPELLE A, Meide HV, Vosman FJH, Visser LH, et al
    A qualitative study assessing patient perspectives in the process of decision-making on disease modifying therapies (DMT's) in multiple sclerosis (MS).
    PLoS One. 2017;12:e0182806.
    PubMed     Text format     Abstract available

  26. ABDELHAK A, Hottenrott T, Mayer C, Hintereder G, et al
    CSF profile in primary progressive multiple sclerosis: Re-exploring the basics.
    PLoS One. 2017;12:e0182647.
    PubMed     Text format     Abstract available

  27. MODICA CM, Schweser F, Sudyn ML, Bertolino N, et al
    Effect of teriflunomide on cortex-basal ganglia-thalamus (CxBGTh) circuit glutamatergic dysregulation in the Theiler's Murine Encephalomyelitis Virus mouse model of multiple sclerosis.
    PLoS One. 2017;12:e0182729.
    PubMed     Text format     Abstract available

  28. KIM BH, Choi HY, Ki M, Kim KA, et al
    Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea.
    PLoS One. 2017;12:e0182391.
    PubMed     Text format     Abstract available

  29. SONG F, Qian Y, Peng X, Li X, et al
    The frontline of immune response in peripheral blood.
    PLoS One. 2017;12:e0182294.
    PubMed     Text format     Abstract available

  30. WASHBURN N, Meccariello R, Hu S, Hains M, et al
    High-resolution physicochemical characterization of different intravenous immunoglobulin products.
    PLoS One. 2017;12:e0181251.
    PubMed     Text format     Abstract available

  31. MANUWALD U, Heinke P, Salzsieder E, Hegewald J, et al
    Incidence trends of type 1 diabetes before and after the reunification in children up to 14 years of age in Saxony, Eastern Germany.
    PLoS One. 2017;12:e0183665.
    PubMed     Text format     Abstract available

  32. MAULUCCI G, Cordelli E, Rizzi A, De Leva F, et al
    Phase separation of the plasma membrane in human red blood cells as a potential tool for diagnosis and progression monitoring of type 1 diabetes mellitus.
    PLoS One. 2017;12:e0184109.
    PubMed     Text format     Abstract available

  33. KARAMPETSOU MP, Comte D, Kis-Toth K, Kyttaris VC, et al
    Expression patterns of signaling lymphocytic activation molecule family members in peripheral blood mononuclear cell subsets in patients with systemic lupus erythematosus.
    PLoS One. 2017;12:e0186073.
    PubMed     Text format     Abstract available

  34. MARITATI F, Alberici F, Oliva E, Urban ML, et al
    Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    PLoS One. 2017;12:e0185880.
    PubMed     Text format     Abstract available

  35. SUGIMOTO K, Nakazato K, Sato A, Suzuki S, et al
    Autoimmune disease mouse model exhibits pulmonary arterial hypertension.
    PLoS One. 2017;12:e0184990.
    PubMed     Text format     Abstract available

  36. KISO K, Yoshifuji H, Oku T, Hikida M, et al
    Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients.
    PLoS One. 2017;12:e0184738.
    PubMed     Text format     Abstract available

  37. ZHU H, Lemos H, Bhatt B, Islam BN, et al
    Carbidopa, a drug in use for management of Parkinson disease inhibits T cell activation and autoimmunity.
    PLoS One. 2017;12:e0183484.
    PubMed     Text format     Abstract available

  38. DIAZ-RIZO V, Bonilla-Lara D, Gonzalez-Lopez L, Sanchez-Mosco D, et al
    Serum levels of adiponectin and leptin as biomarkers of proteinuria in lupus nephritis.
    PLoS One. 2017;12:e0184056.
    PubMed     Text format     Abstract available

  39. NEEDELL JC, Ir D, Robertson CE, Kroehl ME, et al
    Maternal treatment with short-chain fatty acids modulates the intestinal microbiota and immunity and ameliorates type 1 diabetes in the offspring.
    PLoS One. 2017;12:e0183786.
    PubMed     Text format     Abstract available

  40. SILVA-VILCHES C, Pletinckx K, Lohnert M, Pavlovic V, et al
    Low doses of cholera toxin and its mediator cAMP induce CTLA-2 secretion by dendritic cells to enhance regulatory T cell conversion.
    PLoS One. 2017;12:e0178114.
    PubMed     Text format     Abstract available


    Thyroid

  41. HASHIMOTO K, Nishihara E, Matsumoto M, Matsumoto S, et al
    Sialic acid-binding immunoglobulin-like lectin1 as a Novel Predictive Biomarker for Relapse in Graves' Disease -A multicenter study.
    Thyroid. 2017 Oct 17. doi: 10.1089/thy.2017.0244.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: